Literature DB >> 27723728

The type VII secretion system of Staphylococcus aureus secretes a nuclease toxin that targets competitor bacteria.

Zhenping Cao1, M Guillermina Casabona1, Holger Kneuper1, James D Chalmers2, Tracy Palmer1.   

Abstract

The type VII protein secretion system (T7SS) plays a critical role in the virulence of human pathogens including Mycobacterium tuberculosis and Staphylococcus aureus. Here, we report that the S. aureus T7SS secretes a large nuclease toxin, EsaD. The toxic activity of EsaD is neutralized during its biosynthesis through complex formation with an antitoxin, EsaG, which binds to its C-terminal nuclease domain. The secretion of EsaD is dependent on a further accessory protein, EsaE, that does not interact with the nuclease domain, but instead binds to the EsaD N-terminal region. EsaE has a dual cytoplasmic/membrane localization, and membrane-bound EsaE interacts with the T7SS secretion ATPase, EssC, implicating EsaE in targeting the EsaDG complex to the secretion apparatus. EsaD and EsaE are co-secreted, whereas EsaG is found only in the cytoplasm and may be stripped off during the secretion process. Strain variants of S. aureus that lack esaD encode at least two copies of EsaG-like proteins, most probably to protect themselves from the toxic activity of EsaD secreted by esaD+ strains. In support of this, a strain overproducing EsaD elicits significant growth inhibition against a sensitive strain. We conclude that the T7SS may play unexpected and key roles in bacterial competitiveness.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27723728      PMCID: PMC5325307          DOI: 10.1038/nmicrobiol.2016.183

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  52 in total

1.  Contact-dependent inhibition of growth in Escherichia coli.

Authors:  Stephanie K Aoki; Rupinderjit Pamma; Aaron D Hernday; Jessica E Bickham; Bruce A Braaten; David A Low
Journal:  Science       Date:  2005-08-19       Impact factor: 47.728

2.  Bacterial killing via a type IV secretion system.

Authors:  Diorge P Souza; Gabriel U Oka; Cristina E Alvarez-Martinez; Alexandre W Bisson-Filho; German Dunger; Lise Hobeika; Nayara S Cavalcante; Marcos C Alegria; Leandro R S Barbosa; Roberto K Salinas; Cristiane R Guzzo; Chuck S Farah
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

3.  Vectors for improved Tet repressor-dependent gradual gene induction or silencing in Staphylococcus aureus.

Authors:  Leonie Helle; Melanie Kull; Sonja Mayer; Gabriella Marincola; Marc-Eric Zelder; Christiane Goerke; Christiane Wolz; Ralph Bertram
Journal:  Microbiology (Reading)       Date:  2011-09-15       Impact factor: 2.777

4.  Staphylococcal Esx proteins modulate apoptosis and release of intracellular Staphylococcus aureus during infection in epithelial cells.

Authors:  Charalampia G Korea; Giuliana Balsamo; Alfredo Pezzicoli; Christina Merakou; Simona Tavarini; Fabio Bagnoli; Davide Serruto; Meera Unnikrishnan
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

5.  The opportunistic pathogen Serratia marcescens utilizes type VI secretion to target bacterial competitors.

Authors:  Sarah L Murdoch; Katharina Trunk; Grant English; Maximilian J Fritsch; Ehsan Pourkarimi; Sarah J Coulthurst
Journal:  J Bacteriol       Date:  2011-09-02       Impact factor: 3.490

6.  A specific secretion system mediates PPE41 transport in pathogenic mycobacteria.

Authors:  Abdallah M Abdallah; Theo Verboom; Fredericke Hannes; Mohamad Safi; Michael Strong; David Eisenberg; René J P Musters; Christina M J E Vandenbroucke-Grauls; Ben J Appelmelk; Joen Luirink; Wilbert Bitter
Journal:  Mol Microbiol       Date:  2006-11       Impact factor: 3.501

7.  The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Authors:  Tsungda Hsu; Suzanne M Hingley-Wilson; Bing Chen; Mei Chen; Annie Z Dai; Paul M Morin; Carolyn B Marks; Jeevan Padiyar; Celia Goulding; Mari Gingery; David Eisenberg; Robert G Russell; Steven C Derrick; Frank M Collins; Sheldon L Morris; C Harold King; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

8.  Translocation of a Vibrio cholerae type VI secretion effector requires bacterial endocytosis by host cells.

Authors:  Amy T Ma; Steven McAuley; Stefan Pukatzki; John J Mekalanos
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Type VI secretion delivers bacteriolytic effectors to target cells.

Authors:  Alistair B Russell; Rachel D Hood; Nhat Khai Bui; Michele LeRoux; Waldemar Vollmer; Joseph D Mougous
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

View more
  77 in total

1.  The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection.

Authors:  Hideki Hara; Sergey S Seregin; Dahai Yang; Koichi Fukase; Mathias Chamaillard; Emad S Alnemri; Naohiro Inohara; Grace Y Chen; Gabriel Núñez
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

2.  Targeted Depletion of Bacteria from Mixed Populations by Programmable Adhesion with Antagonistic Competitor Cells.

Authors:  See-Yeun Ting; Esteban Martínez-García; Shuo Huang; Savannah K Bertolli; Katherine A Kelly; Kevin J Cutler; Elizabeth D Su; Hui Zhi; Qing Tang; Matthew C Radey; Manuela Raffatellu; S Brook Peterson; Víctor de Lorenzo; Joseph D Mougous
Journal:  Cell Host Microbe       Date:  2020-05-28       Impact factor: 21.023

Review 3.  Pathogen Colonization Resistance in the Gut and Its Manipulation for Improved Health.

Authors:  Joseph M Pickard; Gabriel Núñez
Journal:  Am J Pathol       Date:  2019-05-14       Impact factor: 4.307

4.  Bacterial toxins: A true competitor.

Authors:  Andrea Du Toit
Journal:  Nat Rev Microbiol       Date:  2016-10-24       Impact factor: 60.633

5.  Ixodes scapularis does not harbor a stable midgut microbiome.

Authors:  Benjamin D Ross; Beth Hayes; Matthew C Radey; Xia Lee; Tanya Josek; Jenna Bjork; David Neitzel; Susan Paskewitz; Seemay Chou; Joseph D Mougous
Journal:  ISME J       Date:  2018-06-26       Impact factor: 10.302

Review 6.  Targeting the Achilles' Heel of Bacteria: Different Mechanisms To Break Down the Peptidoglycan Cell Wall during Bacterial Warfare.

Authors:  Stephanie Sibinelli-Sousa; Julia Takuno Hespanhol; Ethel Bayer-Santos
Journal:  J Bacteriol       Date:  2021-03-08       Impact factor: 3.490

7.  Introducing the new bacterial branch of the RNase A superfamily.

Authors:  Bonnie J Cuthbert; Kalistyn H Burley; Celia W Goulding
Journal:  RNA Biol       Date:  2017-11-21       Impact factor: 4.652

8.  Expanding the molecular weaponry of bacterial species.

Authors:  Juvenal Lopez; Mario F Feldman
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

Review 9.  Type VII secretion systems: structure, functions and transport models.

Authors:  Angel Rivera-Calzada; Nikolaos Famelis; Oscar Llorca; Sebastian Geibel
Journal:  Nat Rev Microbiol       Date:  2021-05-26       Impact factor: 60.633

10.  The Pseudomonas aeruginosa T6SS-VgrG1b spike is topped by a PAAR protein eliciting DNA damage to bacterial competitors.

Authors:  Panayiota Pissaridou; Luke P Allsopp; Sarah Wettstadt; Sophie A Howard; Despoina A I Mavridou; Alain Filloux
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.